Company intelligence / Profile preview

Relox Medical

Ownership: Private
Development stage: Other

Overview

Relox Medical held a pharmaceutical patent for a drug intended to treat and promote rapid recovery from traumatic brain injury and/or stroke. As of October 2012, the company had completed various stages of FDA testing and anticipated initiating its final round of clinical trials. No recent updates are available regarding trial results or regulatory progress.

Therapeutic areas: Neurology
Modalities: Small molecule
Industry: Biotech

Partnerships

Proposed acquisition by Insight Management Corporation

Beyond the preview

Go deeper on Relox Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Relox Medical.

Explore the full profile